Accessible molecular tests for allergies and intolerances via a digital health platform.
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Funding round Lithuanian Self.co raised €2.56M, between a round led by Iron Wolf Capital and a grant from the Innovation Agency Lithuania, to expand its accessible allergy testing across Europe. | $3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.